Long-term therapy of heart failure with prazosin: a randomized double blind trial.
暂无分享,去创建一个
[1] L. Benet,et al. Attenuation of prazosin effect on cardiac output in chronic heart failure. , 1979, Annals of internal medicine.
[2] E. Sonnenblick,et al. Marked early attenuation of hemodynamic effects of oral prazosin therapy in chronic congestive heart failure. , 1979, The American journal of cardiology.
[3] J A Parker,et al. Regional Ejection Fraction A Quantitative Radionuclide Index of Regional Left Ventricular Performance , 1979, Circulation.
[4] B. Brundage,et al. Paradox of improved exercise but not resting hemodynamics with short-term prazosin in chronic heart failure. , 1979, The American journal of cardiology.
[5] G. Nicolosi,et al. Alpha-adrenergic blocking activity of prazosin. Effect on catecholamine levels and catecholamine synthetic enzymes. , 1979, Biochemical pharmacology.
[6] R. Gorlin,et al. Hemodynamic and Clinical Tachyphylaxisc to Prazosin-Mediated Afterload Reductionin Severe Chronic Congestive Heart Failure , 1979, Circulation.
[7] W. Pettinger,et al. Drug therapy. Prazosin. , 1979, The New England journal of medicine.
[8] W. Aronow,et al. Effect of Prazosin vs Placebo on Chronic Left Ventricular Heart Failure , 1979, Circulation.
[9] M. Packer,et al. Oral vasodilator therapy for chronic heart failure: a plea for caution. , 1978, The American journal of cardiology.
[10] W R Brody,et al. Ejection fraction by count rate from gated images. , 1978, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[11] S. Snyder,et al. Prazosin: differential affinities for two populations of α-noradrenergic receptor binding sites , 1978 .
[12] J A Parker,et al. Ejection fraction image: a noninvasive index of regional left ventricular wall motion. , 1978, The American journal of cardiology.
[13] C. Conti,et al. Comparative hemodynamic effects of intravenous nitroprusside and oral prazosin in refractory heart failure. , 1978, The American journal of cardiology.
[14] R. Miller,et al. Comparison of Effects of Nitroprusside and Prazosin on Left Ventricular Function and the Peripheral Circulation in Chronic Refractory Congestive Heart Failure , 1978, Circulation.
[15] R. Miller,et al. Efficacy of Ambulatory Systemic Vasodilator Therapy with Oral Prazosin in Chronic Refractory Heart Failure: Concomitant Relief of Pulmonary Congestion and Elevation of Pump Output Demonstrated by Improvements in Symptomatology, Exercise Tolerance, Hemodynamics and Echocardiography , 1977, Circulation.
[16] E. Braunwald. Vasodilator therapy--a physiologic approach to the treatment of heart failure. , 1977, The New England journal of medicine.
[17] R. Miller,et al. Sustained reduction of cardiac impedance and preload in congestive heart failure with the antihypertensive vasodilator prazosin. , 1977, The New England journal of medicine.
[18] J. Cohn,et al. Vasodilator therapy of cardiac failure (second of two parts). , 1977, The New England journal of medicine.
[19] J. Mahony,et al. LONG‐TERM USE OF PRAZOSIN IN COMBINATION OR ALONE FOR TREATING HYPERTENSION , 1977, The Medical journal of Australia.
[20] J A Parker,et al. Radionuclide left ventriculography with the slant hole collimator. , 1977, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[21] J. Cohn,et al. Vasodilator Therapy of Cardiac Failure , 1977 .
[22] W. Parmley,et al. Combination vasodilator therapy for severe chronic congestive heart failure. , 1976, Annals of internal medicine.
[23] R. Miller,et al. Pharmacological Mechanisms for Left Ventricular Unloading in Clinical Congestive Heart Failure: Differential Effects of Nitropmsside, Phentolamine, and Nitroglycerin on Cardiac Function and Peripheral Circulation , 1976, Circulation research.
[24] K. Shine,et al. Vasodilator Therapy for Chronic Left Ventricular Failure , 1976, Circulation.
[25] R Gorlin,et al. Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence of absence of asynergy. , 1976, The American journal of cardiology.
[26] J. Cohn,et al. Hemodynamic Effects of Orally Administered Isosorbide Dinitrate in Patients with Congestive Heart Failure , 1974, Circulation.
[27] J. Cohn,et al. Treatment of refractory heart failure with infusion of nitroprusside. , 1974, The New England journal of medicine.
[28] W. Mroczek,et al. Prazosin in hypertension: a double-blind evaluation with methyldopa and placebo. , 1974, Current therapeutic research, clinical and experimental.
[29] S. Z. Langer,et al. Presynaptic regulation of catecholamine release. , 1974, Biochemical pharmacology.
[30] J. Koch-weser. Vasodilation for Vasospastic Hypertension , 1973 .
[31] W. Campbell,et al. Adrenergic Component of Renin Release Induced by Vasodilating Antihypertensive Drugs in the Rat , 1973, Circulation research.
[32] G. Williams,et al. Double antibody radioimmunoassay of renin activity and angiotensin II in human peripheral plasma. , 1973, The Journal of laboratory and clinical medicine.
[33] W. Henry,et al. Asymmetric Septal Hypertrophy: Echocardiographic Identification of the Pathognomonic Anatomic Abnormality of IHSS , 1973, Circulation.
[34] E. Braunwald,et al. Alterations in regional hemodynamics in experimental heart failure in conscious dogs. , 1972, Transactions of the Association of American Physicians.
[35] R. Bruce,et al. Exercise stress testing in evaluation of patients with ischemic heart disease. , 1969, Progress in cardiovascular diseases.